TVGN
Tevogen Bio Holdings Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$28.35M
P/E Ratio
—
EPS
$-8.08
Beta
0.10
52W High
$75.50
52W Low
$4.13
50-Day MA
$6.36
200-Day MA
$23.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. The company is headquartered in Warren, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-25.95M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -416.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-4.24 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 10.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.19M |
| Float | $1.06M |
| % Insiders | 74.41% |
| % Institutions | 3.40% |
Historical Volatility
HV 10-Day
79.28%
HV 20-Day
117.16%
HV 30-Day
112.46%
HV 60-Day
127.15%
HV Rank
81.7%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/14/2026